BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Al-Karmalawy AA, Soltane R, Abo Elmaaty A, Tantawy MA, Antar SA, Yahya G, Chrouda A, Pashameah RA, Mustafa M, Abu Mraheil M, Mostafa A. Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview. Vaccines (Basel) 2021;9:1317. [PMID: 34835248 DOI: 10.3390/vaccines9111317] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Elagawany M, Elmaaty AA, Mostafa A, Abo Shama NM, Santali EY, Elgendy B, Al-Karmalawy AA. Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease. J Enzyme Inhib Med Chem 2022;37:2112-32. [PMID: 35912578 DOI: 10.1080/14756366.2022.2105322] [Reference Citation Analysis]
2 Wyman KA, Girgis AS, Surapaneni PS, Moore JM, Abo Shama NM, Mahmoud SH, Mostafa A, Barghash RF, Juan Z, Dobaria RD, Almalki AJ, Ibrahim TS, Panda SS. Synthesis of Potential Antiviral Agents for SARS-CoV-2 Using Molecular Hybridization Approach. Molecules 2022;27:5923. [DOI: 10.3390/molecules27185923] [Reference Citation Analysis]
3 Sahoo R, Sahu P, Swargam S, Kumari I, Behera B. Repurposing small molecules of Tephrosia purpurea against SARS-CoV-2 main protease. J Biomol Struct Dyn 2022;:1-12. [PMID: 35983619 DOI: 10.1080/07391102.2022.2112616] [Reference Citation Analysis]
4 Pashameah RA, El-sharnouby M, El-askary A, El-morsy MA, Ahmed HA, Menazea AA. Optical, Structural, Electrical Characterization of (Polyvinyl Alcohol–Carboxymethyl Cellulose-Manganese Dioxide) Nanocomposite Fabricated via Laser Ablation. J Inorg Organomet Polym. [DOI: 10.1007/s10904-022-02311-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ashour NA, Abo Elmaaty A, Sarhan AA, Elkaeed EB, Moussa AM, Erfan IA, Al-Karmalawy AA. A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval. Drug Des Devel Ther 2022;16:685-715. [PMID: 35321497 DOI: 10.2147/DDDT.S354841] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 El-masry RM, Al-karmalawy AA, Alnajjar R, Mahmoud SH, Mostafa A, Kadry HH, Abou-seri SM, Taher AT. Newly synthesized series of oxoindole–oxadiazole conjugates as potential anti-SARS-CoV-2 agents: in silico and in vitro studies. New J Chem 2022;46:5078-90. [DOI: 10.1039/d1nj04816c] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
7 Chowdhury MNR, Alif YA, Alam S, Emon NU, Richi FT, Zihad SMNK, Taki MTI, Rashid MA. Theoretical effectiveness of steam inhalation against SARS-CoV-2 infection: updates on clinical trials, mechanism of actions, and traditional approaches. Heliyon 2022;8:e08816. [PMID: 35097233 DOI: 10.1016/j.heliyon.2022.e08816] [Reference Citation Analysis]
8 Elebeedy D, Badawy I, Elmaaty AA, Saleh MM, Kandeil A, Ghanem A, Kutkat O, Alnajjar R, Abd El Maksoud AI, Al-Karmalawy AA. In vitro and computational insights revealing the potential inhibitory effect of Tanshinone IIA against influenza A virus. Comput Biol Med 2021;141:105149. [PMID: 34953359 DOI: 10.1016/j.compbiomed.2021.105149] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]